Vaccine Market, By Type (Subunit & Conjugate Vaccine, Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Toxoid Vaccine, and Next-generation Vaccine), By Disease Type (Pneumococcal Disease, Diphtheria, Tetanus, & Pertussis (DTP), Influenza, Cancer, Human Papilloma Virus (HPV), and Other Diseases), By Route of Administration (Intramuscular (IM) Vaccine, Subcutaneous Vaccine, Oral Vaccine, Intravenous (IV) Vaccine, and Other Vaccines), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI381320 | Publish Date: August 2023 | No. of Pages: 165

Global Vaccine Market By Type Overview

Introduction:

Vaccines are used to protect individuals against deadly diseases. Immunity is produced by vaccines by injecting agents and components inside the body. Vaccines highly decrease the chances of infection by working with the natural defense of the body to safely develop immunity to a disease. Vaccines are manufactured for the control of the endemic situation and at the time of the outbreak of the disease. They are also developed based on the type of information about the disease. Adjuvants are used in the vaccine to increase the immune response and improve the efficiency of the vaccine. There are various safety and efficacy issues associated with the vaccines. Moreover, to deal with these problems, next-generation vaccines are developed. Currently, next-generation vaccines are in the product pipeline which includes recombinant viral vector vaccines, DNA vaccines, and individualized vaccines. Individualized vaccines are developed based on the genotype and phenotype immune response of an individual. The Vaccine Market accounted for US$ 50.07 billion in 2020 and is estimated to be US$ 102.97 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global Vaccine Market By Type Dynamics

Increasing incidence of infectious disease

Increasing incidence of infectious disease globally is the major driving factor for the global vaccine market growth. Also, growing population, increase in health expenditure, ageing population, rising awareness regarding healthcare, rising cases of viral infection are the factors projected to propel the growth of the global market over the forecast period.

Funding for R&D by government

Major players in the vaccines market are focusing on creating a strong network of distributors and deals. Local authority and government of various countries are funding for R&D activities of vaccines. Players are partnering with other vaccines manufactures, to boost their product portfolio as well as to expand its global presence. As many governments across the world recognize the benefits of vaccination, the trend of vaccines delivering in healthcare solutions on a large scale is continuing. However, longer timelines required to produce vaccines and high monetary inputs linked with the same restrictions the target market growth. Nevertheless, the high growth of vaccine production in emerging markets is anticipated to offer numerous growth opportunities over the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Vaccine Market By Type Segmentation

 

The global vaccine market is segmented based on type, disease type, route of administration, and region.

Based on type, the global vaccine market is segmented into subunit & conjugate vaccine, live attenuated vaccine, inactivated vaccine, recombinant vaccine, toxoid vaccine, and next-generation vaccine. Based on disease type, the target market is classified into pneumococcal disease, diphtheria, tetanus, & pertussis (DTP), Influenza, Cancer, Human papillomavirus (HPV), and other diseases. Based on the route of administration, the global market is segmented into the intramuscular (IM) vaccine, subcutaneous vaccine, oral vaccine, intravenous (IV) vaccine, and other vaccines.

Regional Insights:

For detailed understanding of market dynamics, based on the region the global vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to dominate the global vaccines market, owing to high healthcare expenditure, rising awareness regarding prevention of diseases, and developed medical infrastructure in the region. Whereas, the market in the Asia Pacific is projected to be an emerging market for vaccines and is expected to register the highest CAGR in over the forecasted period. This is mainly attributed due to increasing incidence of viral and infectious disease and the growing geriatric population.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Detailed Segmentation:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Type- Subunit & Conjugate Vaccine, Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Toxoid Vaccine, and Next-generation Vaccine

By Disease Type- Pneumococcal Disease, Diphtheria, Tetanus, & Pertussis (DTP), Influenza, Cancer, Human Papillomavirus (HPV), And Other Diseases

By Route of Administration- Intramuscular (IM) Vaccine, Subcutaneous Vaccine, Oral Vaccine, Intravenous (IV) Vaccine, And Other Vaccines

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

 

Detailed Segmentation:

Global Vaccine Market, By Type:

  • Subunit & Conjugate Vaccine
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Recombinant Vaccine
  • Toxoid Vaccine
  • Next-generation Vaccine

Global Vaccine Market, By Disease Type:

  • Pneumococcal Disease
  • Diphtheria, Tetanus, & Pertussis (DTP)
  • Influenza
  • Cancer
  • Human Papilloma Virus (HPV)
  • Other Diseases

Global Vaccine Market, By Route of Administration:

  • Intramuscular (IM) Vaccine
  • Subcutaneous Vaccine
  • Oral Vaccine
  • Intravenous (IV) Vaccine
  • Other Vaccines

Global Vaccine Market, By Region:

      • North America
        • North America Vaccine Market, By Type
        • North America Vaccine Market, By Disease Type
        • North America Vaccine Market, By Route of Administration
        • North America Vaccine Market, By Country
          • The U.S.
          • Canada
      • Europe
        • Europe Vaccine Market, By Type
        • Europe Vaccine Market, By Disease Type
        • Europe Vaccine Market, By Route of Administration
        • Europe Vaccine Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Vaccine Market, By Type
        • Asia Pacific Vaccine Market, By Disease Type
        • Asia Pacific Vaccine Market, By Route of Administration
        • Asia Pacific Vaccine Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
        • Latin America Vaccine Market, By Type
        • Latin America Vaccine Market, By Disease Type
        • Latin America Vaccine Market, By Route of Administration
        • Latin America Vaccine Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Vaccine Market, By Type
        • Middle East & Africa Vaccine Market, By Disease Type
        • Middle East & Africa Vaccine Market, By Route of Administration
        • Middle East & Africa Vaccine Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Vaccine Market By Type Key Players

The key players operating the global vaccine market involves Abbott Laboratories, Inc., AstraZeneca Plc, BiondVax Pharmaceuticals Ltd., Merck & Co., Inc., Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Emergent BioSolutions, Inc., GlaxoSmithKline Plc, and Inovio Pharmaceuticals, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in 2017, Merck & Co. collaborated with Premier, Inc. (U.S) to develop a preventive care model. The collaboration was based to improve adolescent and adult vaccination rates.

Global Vaccine Market By Type Company Profile

      • Abbott Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • AstraZeneca Plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • BiondVax Pharmaceuticals, Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Bavarian Nordic
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • CSL Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Daiichi Sankyo Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Emergent BioSolutions, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • GlaxoSmithKline Plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Inovio Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance

Global Vaccine Market By Type Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Vaccine Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Disease Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Vaccine Market, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Subunit & Conjugate Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Live Attenuated Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Inactivated Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Recombinant Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Toxoid Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Next-generation Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Vaccine Market, By Disease Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pneumococcal Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diphtheria, Tetanus, & Pertussis (DTP)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Influenza
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Human Papilloma Virus (HPV)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Vaccine Market, By Route of Administration, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Intramuscular (IM) Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Subcutaneous Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Oral Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Intravenous (IV) Vaccine
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Vaccine Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Disease Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Route of Administration, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • Abbott Laboratories, Inc.*
        • Company Overview
        • Type Portfolio
        • Key Highlights
        • Financial Overview
  • AstraZeneca plc
  • BiondVax Pharmaceuticals, Ltd.
  • Merck & Co., Inc.
  • Bavarian Nordic
  • CSL Limited
  • Daiichi Sankyo Company
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline plc
  • Inovio Pharmaceuticals, Inc.
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global vaccine market is segmented based on type, disease type, route of administration, and region.

Increasing incidence of infectious disease globally is the major driving factor for the global vaccine market growth.

The market in North America is estimated to dominate the global vaccines market, owing to high healthcare expenditure, rising awareness regarding prevention of diseases, and developed medical infrastructure in the region.

The key players operating the global vaccine market involves Abbott Laboratories, Inc., AstraZeneca Plc, BiondVax Pharmaceuticals Ltd., Merck & Co., Inc., Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Emergent BioSolutions, Inc., GlaxoSmithKline Plc, and Inovio Pharmaceuticals, Inc.